Brugada Syndrome
Conditions
Brief summary
Current treatment of high-risk Brugada Syndrome (BrS) patients (pts) with recurrent VF is limited. Catheter ablation (CA) has been performed for BrS but a large study with long-term outcomes of CA in BrS ablation are lacking.
Detailed description
Brugada syndrome (BrS) patients who undergo BRS substrate ablations from tertiary centers for catheter ablations of complex arrhythmias from three continents - Asia, Europe and North America - are registered in a common database. The investigators exclude patients who were lost to follow up in the outpatient clinic.
Interventions
PROCEDURECatheter Ablation
Ventricular fibrillation substrate
Sponsors
University Hospital, Bordeaux
University of Tsukuba
University of London
University of Amsterdam
Ogaki Municipal Hospital
Indiana University
Taipei Veterans General Hospital, Taiwan
Zhejiang University
Pacific Rim Electrophysiology Research Institute
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No
Inclusion criteria
* Symptomatic Brugada Syndrome patients who had undergone catheter ablation of the arrhythmogenic substrates.
Exclusion criteria
* Patients who will not commit to regular follow up.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Death | 3 years | Expiration, unrelated to procedure |
| ICD Therapy for VT/VF | 3 years | Electrical therapy delivered through device for termination of VF episodes |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Inappropriate ICD Therapy | 3 years | Caused by lead sensing or programming errors |
| Normalization of Brugada ECG pattern | 3 years | ECG pattern is normal sinus rhythm after catheter ablation |
Countries
Thailand
Outcome results
None listed